TOP > > Kazunori Kataoka
Kazunori Kataoka 片岡 一則
Scientists website
The survival rate for pancreat ic cancer patients is extremely low, and this cancer is known as an intractable cancer. We found that nanocapsules with precisely controlled sizes in a nanometer scale can effectively penetrate into pancreat ic cancer tissue and significantly improve effectiveness of chemotherapy. There are high expectations for nanocapsules as a breakthrough in the t reatment of pancreatic cancer.

Anytime, Anywhere, Anyone:Medical Innovation by Nanobiotechnology
By precisely synthesizing polymersegments , the material of nanocapsules, the polymer segments self-assemble spontaneously in liquid to form capsules; the capsules then assemble at the affected site and release the drug.

Development of innovative diagnostic and therapeutic systems based on Nanobiotechnology One nanometer is a microscopic or atomic/molecular scale equivalent to 1/1,000,000 of a millimeter. Nanobiotechnology is a new field fusing nanotechnology which controls substances in the nano-scale and biotechnology (bioengineering). To date, we have been carrying out studies on the medical applications of nanobiotechnology, such as creating nanocapsules designed in the nano-scale, and using them for delivering drugs to the diseased site. Expanding on this, we hope to build an integrated medical system capable of diagnosis and treatment.
Targeting cancer, the leading cause of deaths in Japan, our goal is to create various nanoscale biofunctional devices useful in all stages of medical care ranging from diagnosis to treatment. This includes the accurate detection of signs of illness and sites of disease through early and precise diagnosis, appropriate combination of surgical and internal treatment according to the disease state, highly effective and safe treatment, and reconstruction of the affected area after treatment.


Quality and safe medical care available "anytime, anywhere, and to anyone" Our nanobio devices are capable of enhancing the effects of drugs, reducing side-effects, enhancing the quality of life (QOL) of patients, reducing the amount of expensive drugs, reducing costs by mass production, and disseminating new treatments to many medical institutions, thereby providing high quality and safe medical care available anytime, anywhere, and to anyone. We aim to build innovative systems that can provide such care services at reasonable costs. We also hope to create new industries applying nanotechnology, Japan’s forte, to medical care, and contribute to enhancing the country’s competitiveness on the international stage.


figure